Verastem Dividends
| VSTM Stock | USD 6.41 0.31 5.08% |
As of the 1st of February 2026, Dividend Paid And Capex Coverage Ratio is likely to drop to -4,518. Verastem's past performance could be the main factor of why investors trade Verastem stock today. Investors should clearly understand every aspect of the Verastem dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Verastem's dividend schedule and payout information. Verastem dividends can also provide a clue to the current valuation of Verastem.
| Last Reported | Projected for Next Year | ||
| Dividend Paid And Capex Coverage Ratio | -4.3 K | -4.5 K |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Verastem must own a stock before its ex-dividend date to receive its next dividend.
Verastem Dividends Paid Over Time
Today, most investors in Verastem Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Verastem's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Verastem dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Will Biotechnology sector continue expanding? Could Verastem diversify its offerings? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Verastem data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (4.07) | Revenue Per Share | Quarterly Revenue Growth (0.79) | Return On Assets | Return On Equity |
The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Verastem's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.